Daniel C. Betticher, MD [clinicaltrials_resource:3b7ce8f1c75a0525d7a924290269bab6]
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003215]Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00003231]Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00217698]
overall official [clinicaltrials_vocabulary:overall-official]
Daniel C. Betticher, MD [clinicaltrials_resource:3b7ce8f1c75a0525d7a924290269bab6]
Bio2RDF identifier
3b7ce8f1c75a0525d7a924290269bab6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3b7ce8f1c75a0525d7a924290269bab6
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Daniel C. Betticher, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:3b7ce8f1c75a0525d7a924290269bab6
title
Daniel C. Betticher, MD
@en
type
label
Daniel C. Betticher, MD [clinicaltrials_resource:3b7ce8f1c75a0525d7a924290269bab6]
@en